Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May;7(5):169-179.
doi: 10.1177/2045125317693513. Epub 2017 Mar 27.

Effectiveness of paliperidone depot injection in seriously violent men with comorbid schizophrenia and dissocial personality disorder in a UK high-security hospital

Affiliations

Effectiveness of paliperidone depot injection in seriously violent men with comorbid schizophrenia and dissocial personality disorder in a UK high-security hospital

Anna-Marie Mortlock et al. Ther Adv Psychopharmacol. 2017 May.

Abstract

Background: High-security hospital patients are often complex in presentation and are characterized by treatment resistance, medication nonadherence and history of violence. Paliperidone is licensed both as an oral and depot antipsychotic medication in the treatment of schizophrenia. Clinical trials have shown that paliperidone depot is well tolerated with similar efficacy to risperidone depot but with additional practical advantages. Whilst data exist for the effectiveness of paliperidone palmitate (PP), there are no studies involving patients in forensic settings or those with comorbid personality disorder. Our aim was to evaluate the effectiveness of PP on violence, aggression and personality disorder symptoms.

Methods: This project was a retrospective service evaluation involving 11 patients, carried out in a high-security hospital. A combination of patient records and interviews with the treating consultant psychiatrist were used to ascertain a Clinical Global Impression (CGI) score, the effect of PP on specific personality disorder symptom domains (cognitive-perceptual, impulsive-behavioural dyscontrol and affective dysregulation) and incidents of violence and aggression. Engagement with occupational and psychological therapies was also evaluated. Metabolic parameters were reviewed.

Results: A total of 6 out of 11 patients continued on PP, most of whom had schizophrenia and dissocial personality disorder with histories of violence. All showed improvement in the CGI score with associated benefits in the three personality symptom domains. Overall, two patients demonstrated a reduction in the risk of violence. There was improvement in engagement with occupational therapy and psychological work. No significant effects on metabolic parameters were noted although hyperprolactinaemia, albeit asymptomatic, was consistently recorded.

Conclusions: This pragmatic service evaluation of a small but complex patient group demonstrated, for the first time, that PP was effective in reducing violence as well as improving personality pathology across all dimensions: a finding which could have significant implications for management of such high-security patients.

Keywords: antipsychotic agents; depot antipsychotic; high-security; paliperidone; personality disorder; schizophrenia; violence.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors declare that there is no conflict of interest.

Figures

Figure 1.
Figure 1.
Number of incidents and aggressive episodes before and after starting PP. PP, paliperidone palmitate.

Similar articles

References

    1. Adams D. (1979) Brain mechanisms for offence, defence, and submission. Behav Brain Sci 2: 201–213.
    1. Baruch N., Das M., Sharda A., Basu A., Bajorek T., Ross C., et al. (2014) An evaluation of the use of olanzapine pamoate depot injection in seriously violent men with schizophrenia in a UK high-security hospital. Ther Adv Psychopharmacol 4: 186–192. - PMC - PubMed
    1. Berman M., Tracy J., Coccaro E. (1997) The serotonin hypothesis of aggression revisited. Clin Psychol Rev 17: 651–665. - PubMed
    1. Binks C., Fenton M., McCarthy L., Lee T., Adams C., Duggan C. (2006) Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev CD005653. - PubMed
    1. Bishara D. (2010) Once-monthly paliperidone injection for the treatment of schizophrenia. Neuropsychiatr Dis Treat 6: 561–572. - PMC - PubMed

LinkOut - more resources